ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.80
0.45%
US Tech 100
18,054.05
-0.14%
S&P 500
5,298.12
0.02%
US Dollar vs CAD
1.36175
0.02%
Bitcoin
66,872.02
2.51%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. InVivo Therapeutics Holdings Corporation (NVIV)

  7. InVivo Therapeutics Holdings Corporation (NVIV) News

NVIV

InVivo Therapeutics (NVIV)

InVivo Therapeutics Holdings Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NVIV
DateTimeSourceHeadlineSymbolCompany
03/21/20241:23PMEdgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/14/20241:53PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/13/20247:09PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/07/20241:12PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/07/202412:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/06/202411:08AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/06/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/01/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
12/05/20237:35AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
12/05/20237:30AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
12/01/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/30/20239:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/08/20233:31PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/01/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/09/20233:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
05/12/20233:48PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
04/25/20234:38PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
03/09/20238:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
03/09/20237:55AMBusiness WireInVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord InjuryNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
03/01/20233:35PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/14/202312:13PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/22/20225:03AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/21/20224:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/21/20224:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/21/20224:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/21/20224:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/21/20224:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/21/20224:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/18/20223:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/09/20225:02AMEdgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
 Showing the most relevant articles for your search:NASDAQ:NVIV

Your Recent History

NASDAQ
CRKN
Crown Electrokinetics
NASDAQ
GWAV
Greenwave Technology Sol...
USOTC
CYDY
CytoDyn (QB)
USOTC
GDVM
Global Developments (PK)
USOTC
PLPL
Plandai Biotechnology (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
RONN
Ronn Motor (PK)
USOTC
NLST
Netlist (QB)
USOTC
MIKP
Mike The Pike Productions (CE)
USOTC
STAL
Star Alliance (PK)
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
FDCT
FDCTech (PK)
USOTC
KGKG
Kona Gold Beverage (PK)
COIN
BTCUSD
Bitcoin
NASDAQ
AMRN
Amarin
USOTC
CLNV
Clean Vision (QB)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved